Healthy Inc > Blog > Primaquine 15mg manufacturer India
Posted on:

Is primaquine used in pregnancy?

In the pharmaceutical industry, Primaquine is a potent 8-aminoquinoline antimalarial. As a pharmacist and manufacturer, I must state clearly: Primaquine is strictly contraindicated in pregnancy.

At your WHO-GMP facility in Mumbai, where you produce essential anti-infectives, this molecule requires the highest level of clinical caution. While it is the “gold standard” for the radical cure of P. vivax and P. ovale, its use during pregnancy is a significant safety violation due to the risk of fetal death.

Therapeutic Profile: Why Primaquine is Avoided

The danger of Primaquine in pregnancy is not to the mother, but to the fetus, whose health status cannot be fully verified in utero.

Risk FactorClinical ImpactTechnical Rationale
Fetal HemolysisCritical RiskThe drug crosses the placenta. If the fetus is G6PD deficient, it can suffer life-threatening red blood cell destruction (hemolysis) in the womb.
G6PD UncertaintyDiagnostic GapEven if the mother tests normal for G6PD, the fetus may not be (due to X-linked inheritance). There is currently no safe way to test a fetus’s G6PD status.
TeratogenicityDevelopmental Risk2026 pharmacological data continues to show evidence of embryo-fetal toxicity and potential gene mutations in animal models.
National PolicyStrict BanThe National Drug Policy on Malaria (India) and the WHO (2025/2026 guidelines) explicitly forbid Primaquine for pregnant women.

Mechanism: Placental Transfer & Oxidative Stress

Primaquine’s effectiveness comes from its ability to induce oxidative stress in parasites. However, this same mechanism is its downfall in pregnancy:Passive Diffusion: Primaquine molecules are small enough to pass through the placental barrier and enter the fetal circulation.

Oxidative Attack: Once in the fetal blood, the drug generates reactive oxygen species.

Fetal Vulnerability: A G6PD-deficient fetus lacks the enzyme needed to neutralize these oxidants, leading to rapid destruction of its red blood cells, severe anemia, and potential fetal death.

The Pharmacist’s “Technical Warning”

  • The “Suppressive” Protocol: If a pregnant woman has relapsing malaria (P. vivax), she should be treated with Chloroquine to clear the blood infection and then kept on weekly Chloroquine prophylaxis for the duration of the pregnancy to prevent relapses.

  • Post-Partum Delay: The “Radical Cure” (Primaquine) should only be started after delivery.

  • Breastfeeding Caution: Even after delivery, if the mother is breastfeeding, she cannot take Primaquine until the infant has been tested for G6PD deficiency and confirmed to have normal enzyme activity.

  • Pregnancy Testing: In your clinical marketing, always advise that women of reproductive age should have a confirmed negative pregnancy test before starting a 14-day Primaquine regimen.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Radical Cure” USP: On your digital platforms, promote Primaquine as the essential second step for P. vivax eradication in non-pregnant adults. Highlight its role in preventing the “relapse cycle” that Chloroquine alone cannot stop.

  • Labeling Compliance: Ensure that your packaging clearly displays the “Not for use in pregnancy” warning. This is a critical regulatory requirement for WHO-standard dossiers and international tenders (especially for UNICEF/Global Fund).

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers that include comprehensive safety data and contraindication protocols for pregnancy to assist your global registration efforts.

Primaquine Tablets

Posted on:

How to take primaquine for malaria?

In the pharmaceutical industry, Primaquine Phosphate is a specialized 8-aminoquinoline and the only widely available drug capable of achieving a “radical cure” for malaria. As a pharmacist and manufacturer, I view this molecule as a critical public health tool, specifically designed to target the dormant liver stages of the parasite that other drugs cannot reach.

At your WHO-GMP facility in Mumbai, Primaquine (available in 7.5 mg and 15 mg tablets) is a high-impact SKU for export to malaria-endemic regions in Africa and Southeast Asia.

The Dosing Protocol: “Radical Cure” Strategy

Primaquine is almost never used alone; it is typically taken after or alongside a blood-stage antimalarial (like Chloroquine or an ACT).

  • For P. vivax & P. ovale (Radical Cure): The standard adult dose is 15 mg once daily for 14 days. This is essential to prevent the “relapse” of malaria months or years later.

  • For P. falciparum (Gametocytocidal): A single “low dose” (often 0.25 mg/kg or a flat 15 mg or 45 mg dose) is given as a one-time treatment to stop the transmission of malaria to mosquitoes.

  • Administration: It must be taken with food (a full meal) to significantly reduce the risk of gastrointestinal upset.

Mechanism: Targeting the Hypnozoites

Primaquine works where other antimalarials fail: the human liver.

Tissue Schizonticide: It penetrates liver cells to destroy hypnozoites—the dormant “sleeper” cells of P. vivax and P. ovale.

Gametocytocidal Action: It kills the sexual forms of the parasite (gametocytes) in the blood, preventing the person from passing the infection back to a mosquito.

Mitochondrial Disruption: It interferes with the parasite’s DNA and disrupts its mitochondrial electron transport, effectively “starving” the parasite of energy.

The Pharmacist’s “Critical Warning”

As you promote your firm on digital platforms, this is the most vital technical safety point:

  • The G6PD Crisis: Primaquine can cause life-threatening Hemolytic Anemia in individuals with a G6PD (Glucose-6-Phosphate Dehydrogenase) deficiency.

  • Mandatory Testing: Patients must be tested for G6PD deficiency before starting a 14-day course. If deficient, an alternative weekly dosing schedule (45 mg once weekly for 8 weeks) is sometimes used under strict supervision.

  • Pregnancy Contraindication: It is strictly contraindicated during pregnancy because the G6PD status of the fetus cannot be determined, and it can cause fetal hemolysis.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Radical Cure” USP: On your marketplace, highlight Primaquine as the essential companion to Chloroquine. Many buyers look for these as a “Relapse Prevention Kit”.

  • Stability for Export: Primaquine is stable but light-sensitive. Utilizing Alu-Alu blister packaging ensures a 36-month shelf life, vital for distribution to remote, tropical regions in Zone IVb.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international health tenders (e.g., Global Fund or USAID) for national malaria elimination programs.

Mefloquine Tablets

Add to cart